Noncompetitive blocking of human GLUT1 hexose transporter by methylxanthines reveals an exofacial regulatory binding site

American Journal of Physiology - Cell Physiology

Volumn 303, Issue 5, 2012, Pages

  Ojeda, Paola ^a   Pérez, Alejandra ^a   Ojeda, Lorena ^a   Vargas Uribe, Mauricio ^a   Rivas, Coralia I ^b   Salas, Monica ^a   Vera, Juan Carlos ^a   Reyes, Alejandro M ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Caffeine; Glucose transport; Glucose transporter inhibitors; Human erythrocytes; Pentoxifylline

Indexed keywords

CAFFEINE; CYTOCHALASIN B; GLUCOSE; GLUCOSE TRANSPORTER 1; PENTOXIFYLLINE; THEOPHYLLINE;

ARTICLE; BINDING ASSAY; BINDING KINETICS; CONTROLLED STUDY; DRUG BINDING SITE; DRUG PROTEIN BINDING; ERYTHROCYTE; GLUCOSE TRANSPORT; HEXOSE TRANSPORT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; TRANSPORT KINETICS;

BINDING SITES; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CYTOCHALASIN B; DEOXYGLUCOSE; ERYTHROCYTES; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; PROTEIN CONFORMATION; XANTHINES;

EID: 84865772205     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00145.2012     Document Type: Article

References (52)

1. Augustin R. The protein family of glucose transport facilitators: it's not only about glucose after all. IUBMB Life 62: 315-333, 2010.
2. Basketter DA, Widdas WF. Asymmetry of the hexose transfer system in human erythrocytes. Comparison of the effects of cytochalasin B, phloretin and maltose as competitive inhibitors. J Physiol 278: 389-401, 1978.
3. Bell GI, Burant CF, Takeda J, Gould GW. Structure and function of mammalian facilitative sugar transporters. J Biol Chem 268: 19161-19164, 1993.
4. Bloch R. Inhibition of glucose transport in the human erythrocyte by cytochalasin B. Biochemistry 12: 4799-4801, 1973.
5. Carruthers A. Facilitated diffusion of glucose. Physiol Rev 70: 1135-1176, 1990.
6. C arruthers A, Dezutter J, Ganguly A, Devaskar SU. Will the original glucose transporter isoform please stand up! Am J Physiol Endocrinol Metab 297: E836-E848, 2009.
7. Challiss JR, Taylor LP, Holman GD. Sugar transport asymmetry in human erythrocytes-the effect of bulk haemoglobin removal and the addition of methylxanthines. Biochim Biophys Acta 602: 155-166, 1980.
8. Deves R, Krupka RM. Cytochalasin B and the kinetics of inhibition of biological transport: a case of asymmetric binding to the glucose carrier. Biochim Biophys Acta 510: 339-348, 1978.
9. Deves R, Krupka RM. A new approach in the kinetics of biological transport. The potential of reversible inhibition studies. Biochim Biophys Acta 510: 186-200, 1978.
10. Deves R, Krupka RM. Testing transport systems for competition between pairs of reversible inhibitors. Inhibition of erythrocyte glucose transport by cytochalasin B and steroids. J Biol Chem 255: 11870-11874, 1980.
11. Garber K. Energy deregulation: licensing tumors to grow. Science 312: 1158-1159, 2006.
12. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899, 2004.
13. Haspel HC, Stephenson KN, Davies-Hill T, El-Barbary A, Lobo JF, Croxen RL, Mougrabi W, Koehler-Stec EM, Fenstermacher JD, Simpson IA. Effects of barbiturates on facilitative glucose transporters are pharmacologically specific and isoform selective. J Membr Biol 169: 45-53, 1999.
14. Hellwig B, Joost HG. Differentiation of erythrocyte-(GLUT1), liver- (GLUT2), and adipocyte-type (GLUT4) glucose transporters by binding of the inhibitory ligands cytochalasin B, forskolin, dipyridamole, and isobutylmethylxanthine. Mol Pharmacol 40: 383-389, 1991.
15. Ho YY, Yang H, Klepper J, Fischbarg J, Wang D, De Vivo DC. Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro. Pediatr Res 50: 254-260, 2001.
16. Holman GD, Rees WD. Photolabelling of the hexose transporter at external and internal sites: fragmentation patterns and evidence for a conformational change. Biochim Biophys Acta 897: 395-405, 1987.
17. Hruz PW, Mueckler MM. Structural analysis of the GLUT1 facilitative glucose transporter. Mol Membr Biol 18: 183-193, 2001.
18. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 134: 703-707, 2008.
19. Inukai K, Asano T, Katagiri H, Anai M, Funaki M, Ishihara H, Tsukuda K, Kikuchi M, Yazaki Y, Oka Y. Replacement of both tryptophan residues at 388 and 412 completely abolished cytochalasin Bphotolabelling of the GLUT1 glucose transporter. Biochem J 302: 355- 361, 1994.
20. Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members. Mol Membr Biol 18: 247-256, 2001.
21. Jung CY, Rampal AL. Cytochalasin B binding sites and glucose transport carrier in human erythrocyte ghosts. J Biol Chem 252: 5456-5463, 1977.
22. Kashiwagi A, Huecksteadt TP, Foley JE. The regulation of glucose transport by cAMP stimulators via three different mechanisms in rat and human adipocytes. J Biol Chem 258: 13685-13692, 1983.
23. Krupka RM. Asymmetrical binding of phloretin to the glucose transport system of human erythrocytes. J Membr Biol 83: 71-80, 1985.
24. Krupka RM, Deves R. Evidence for allosteric inhibition sites in the glucose carrier of erythrocytes. Biochim Biophys Acta 598: 127-133, 1980.
25. Lacko L, Wittke B. The competitive inhibition of glucose transport in human erythrocytes by compounds of different structures. Biochem Pharmacol 31: 1925-1929, 1982.
26. Lacko L, Wittke B, Geck P. Interaction of steroids with the transport system of glucose in human erythrocytes. J Cell Physiol 86, Suppl 2: 673-680, 1975.
27. Lacko L, Wittke B, Zimmer G. Interaction of benzoic acid derivatives with the transport system of glucose in human erythrocytes. Biochem Pharmacol 30: 1425-1431, 1981.
28. Lefevre PG, Marshall JK. The attachment of phloretin and analogues to human erythrocytes in connection with inhibition of sugar transport. J Biol Chem 234: 3022-3026, 1959.
29. Macheda M, Rogers S, Best J. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202: 654-662, 2005.
30. Medina RA, Owen GI. Glucose transporters: expression, regulation and cancer. Biol Res 35: 9-26, 2002.
31. Mueckler M. Facilitative glucose transporters. Eur J Biochem 219: 713-725, 1994.
32. Newsholme EA, & Board M. Application of metabolic-control logic to fuel utilization and its significance in tumor cells. Adv Enzyme Regul 31: 225-246, 1991.
33. Perez A, Ojeda P, Ojeda L, Salas M, Rivas CI, Vera JC, Reyes AM. Hexose transporter GLUT1 harbors several distinct regulatory binding sites for flavones and tyrphostins. Biochemistry 50: 8834-8845, 2011.
34. Perez AA, Ojeda PG, Valenzuela XE, Ortega MS, Sanchez C, Ojeda L, Castro MA, Carcamo JG, Rauch C, Concha II, Rivas CI, Vera JC, Reyes AM. Endofacial competitive inhibition of the glucose transporter-1 activity by gossypol. Am J Physiol Cell Physiol 297: C86-C93, 2009.
35. Rampal AL, Pinkofsky HB, Jung CY. Structure of cytochalasins and cytochalasin B binding sites in human erythrocyte membranes. Biochemistry 19: 679-683, 1980.
36. Salas-Burgos A, Iserovich P, Zuniga F, Vera JC, Fischbarg J. Predicting the three-dimensional structure of the human facilitative glucose transporter Glut1 by a novel evolutionary homology strategy: insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules. Biophys J 87: 2990-2999, 2004.
37. Sato Y, Miura T, Suzuki Y. Interaction of pentoxifylline with human erythrocytes. I. Interaction of xanthine derivatives with human erythrocyte ghosts. Chem Pharm Bull (Tokyo) 38: 552-554, 1990.
38. Sato Y, Miura T, Suzuki Y. Interaction of pentoxifylline with human erythrocytes. II. Effects of pentoxifylline on the erythrocyte membrane. Chem Pharm Bull (Tokyo) 38: 555-558, 1990.
39. Sato Y, Miura T, Suzuki Y. Interaction of pentoxifylline with human erythrocytes. III. Comparison of fluidity change of erythrocyte membrane caused by S-adenosyl-L-methionine with that by pentoxifylline. Chem Pharm Bull (Tokyo) 39: 468-473, 1991.
40. Segel IH. Multiple inhibition analysis. In: Enzyme kinetics. New York: Wiley, 1975, p. 465-503.
41. Sen AK, Widdas WF. Determination of the temperature and pH dependence of glucose transfer across the human erythrocyte membrane measured by glucose exit. J Physiol 160: 392-403, 1962.
42. Slot JW, Geuze HJ, Gigengack S, Lienhard GE, James DE. Immunolocalization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J Cell Biol 113: 123-135, 1991.
43. Steck TL, Kant JA. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol 31: 172-180, 1974.
44. Steinfelder HJ, Joost HG. Inhibition of insulin-stimulated glucose transport in rat adipocytes by nucleoside transport inhibitors. FEBS Lett 227: 215-219, 1988.
45. Steinfelder HJ, Petho-Schramm S. Methylxanthines inhibit glucose transport in rat adipocytes by two independent mechanisms. Biochem Pharmacol 40: 1154-1157, 1990.
46. Thorens B. Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am J Physiol Gastrointest Liver Physiol 270: G541-G553, 1996.
47. Vera J, Reyes A, Velásquez F, Rivas C, Zhang R, Strobel P, Slebe J, Nuñez-Alarcón J, Golde D. Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors. Biochemistry 40: 777-790, 2001.
48. Vera JC, Reyes AM, Carcamo JG, Velasquez FV, Rivas CI, Zhang RH, Strobel P, Iribarren R, Scher HI, Slebe JC. Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter, GLUT1. J Biol Chem 271: 8719-8724, 1996.
49. Vera JC, Reyes AM, Velasquez FV, Rivas CI, Zhang RH, Strobel P, Slebe JC, Nunez-Alarcon J, Golde DW. Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors. Biochemistry 40: 777- 790, 2001.
50. Ward A, Clissold SP. Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34: 50-97, 1987.
51. Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res 56: 1164-1167, 1996.
52. Zhang M, Xu YJ, Mengi SA, Arneja AS, Dhalla NS. Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. Exp Clin Cardiol 9: 103-111, 2004.